Unknown PHASE3 INTERVENTIONAL 2-arm NCT03304444

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

A Pilot Study: A Comparison of Liposomal Bupivacaine to Bupivacaine HCl in Transversus Abdominis Planus Block for Abdominal Gynecologic Surgery

Sponsor: Abington Memorial Hospital

Conditions Gynecologic Cancer Post Operative Pain

Interventions Bupivacaine liposomal bupivacaine

Updated 6 times since 2017 Last updated: Oct 3, 2017 Started: Aug 31, 2016 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Gynecologic Cancer and Post Operative Pain, this trial is ongoing. The trial is conducted by Abington Memorial Hospital and has accumulated 6 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Nov 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abington Memorial Hospital

Data source: Abington Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Abington, United States